This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

W. T. Brown, MD
Department of Psychiatry

P. R. Sanberg, Msc; P. L. McGeer, MD, PhD
Kinsmen Laboratory of Neurological Research Department of Psychiatry University of British Columbia 2075 Wesbrook Mall Vancouver, Canada

Arch Neurol. 1979;36(7):452-453.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In an article in the ARCHIVES (35:53-54, 1978), Green reported improvement after treatment with corticosteroids in the conditions of eight consecutive patients suffering from Sydenham's chorea (SC). Green suggested that the beneficial effect of corticosteroids on SC may involve alleviating "a mild inflammatory reaction of small vessels most likely involving the caudate-putamen complex." Another possibility worth consideration is that his results reflect suppression of an autoimmune mechanism. Recent work by Husby et al¹ suggests that, in SC, an "antineuronal" antibody is present that reacts with the neuronal cytoplasm of human caudate. It is possible that corticosteroids, by reducing production of such an antibody, might bring about a favorable therapeutic response. If this is true, a similar approach might be considered for the treatment of Huntington's disease (HD), inasmuch as there have also been reports of an autoimmune response in this disorder.

McMenemy in 1961² first . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?